Cancel anytime
CLARIVATE PLC (CLVT)CLVT
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/04/2024: CLVT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: -39.3% | Upturn Advisory Performance 1 | Avg. Invested days: 35 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/04/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: -39.3% | Avg. Invested days: 35 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/04/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.08B USD |
Price to earnings Ratio - | 1Y Target Price 6.27 |
Dividends yield (FY) - | Basic EPS (TTM) -1.99 |
Volume (30-day avg) 2774218 | Beta 1.18 |
52 Weeks Range 4.25 - 9.61 | Updated Date 12/4/2024 |
Company Size Mid-Cap Stock | Market Capitalization 4.08B USD | Price to earnings Ratio - | 1Y Target Price 6.27 |
Dividends yield (FY) - | Basic EPS (TTM) -1.99 | Volume (30-day avg) 2774218 | Beta 1.18 |
52 Weeks Range 4.25 - 9.61 | Updated Date 12/4/2024 |
Earnings Date
Report Date 2024-11-06 | When Before Market |
Estimate 0.19 | Actual 0.19 |
Report Date 2024-11-06 | When Before Market | Estimate 0.19 | Actual 0.19 |
Profitability
Profit Margin -50% | Operating Margin (TTM) 11.46% |
Management Effectiveness
Return on Assets (TTM) 1.3% | Return on Equity (TTM) -21.14% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 8.17 |
Enterprise Value 8408820510 | Price to Sales(TTM) 1.58 |
Enterprise Value to Revenue 3.25 | Enterprise Value to EBITDA -3.99 |
Shares Outstanding 710403968 | Shares Floating 400077977 |
Percent Insiders 15.85 | Percent Institutions 91.79 |
Trailing PE - | Forward PE 8.17 | Enterprise Value 8408820510 | Price to Sales(TTM) 1.58 |
Enterprise Value to Revenue 3.25 | Enterprise Value to EBITDA -3.99 | Shares Outstanding 710403968 | Shares Floating 400077977 |
Percent Insiders 15.85 | Percent Institutions 91.79 |
Analyst Ratings
Rating 3.6 | Target Price 8.5 | Buy 1 |
Strong Buy 3 | Hold 5 | Sell 1 |
Strong Sell - |
Rating 3.6 | Target Price 8.5 | Buy 1 | Strong Buy 3 |
Hold 5 | Sell 1 | Strong Sell - |
AI Summarization
CLARIVATE PLC: A Comprehensive Overview
Company Profile
History and Background
Clarivate Plc is a global leader in providing information and analytics solutions to academic, government, and corporate customers. Founded in 2016 following the acquisition of Thomson Reuters' Intellectual Property & Science business by Onex Corporation and Baring Private Equity Asia, the company has a rich history dating back to the early 19th century with the founding of the Institute for Scientific Information (ISI) by Eugene Garfield.
Throughout the years, Clarivate has grown through strategic acquisitions and organic expansion. In 2019, Clarivate went public on the New York Stock Exchange (NYSE: CLVT). Today, the company operates in over 100 countries and employs approximately 12,000 people.
Core Business Areas
Clarivate's business is organized around three core segments:
- Science & Academic Research: This segment provides solutions for researchers and academics, including Web of Science, EndNote, and Publons.
- Intellectual Property & Standards: This segment offers patent research and analytics tools, including Derwent Innovation, CompuMark, and MarkMonitor.
- Pharma & Healthcare: This segment provides solutions for pharmaceutical and life sciences companies, including Cortellis and Integrity.
Leadership and Corporate Structure
Clarivate is led by CEO Jerre Stead, who joined the company in 2019. The executive team also includes several other experienced leaders, such as CFO Richard Hanks, President of Intellectual Property & Standards Jon Collins, and President of Science & Academic Research Jeff Konigsberg.
The company is headquartered in Philadelphia, Pennsylvania, and operates through a global network of offices.
Top Products and Market Share
Top Products and Offerings
- Web of Science: The world's leading citation database, covering over 1.7 billion records of research articles, conference papers, and other scholarly works.
- Derwent Innovation: A patent research and analytics tool, providing access to over 89 million patent records.
- EndNote: A reference management software used by millions of researchers worldwide.
- Cortellis: A drug discovery and development intelligence platform.
- CompuMark: A trademark research and analytics tool.
Market Share
Clarivate holds a strong market position in several of its key segments.
- In the academic research market, Web of Science has a market share of over 50%.
- In the patent research market, Derwent Innovation has a market share of over 35%.
- In the pharmaceutical market, Cortellis is the leading drug discovery intelligence platform.
Total Addressable Market
The total addressable market (TAM) for Clarivate is estimated to be around $25 billion. This includes markets such as academic research, intellectual property, pharmaceuticals, and healthcare.
Financial Performance
Recent Financial Statements
Clarivate has consistently reported strong financial performance in recent years.
- In 2022, the company reported revenue of $1.8 billion, representing a year-over-year increase of 8.5%.
- Net income was $244 million, with a profit margin of 13.5%.
- Earnings per share (EPS) were $1.53.
The company has a strong balance sheet with a low debt-to-equity ratio and significant cash flow.
Dividend and Shareholder Returns
Clarivate has a history of paying dividends to its shareholders. The current annual dividend yield is 0.7%. Over the past five years, total shareholder returns have been approximately 25%.
Growth Trajectory
Clarivate has historically experienced strong growth.
- Over the past five years, revenue has grown at an average annual rate of 7%.
- The company expects to continue growing at a similar pace in the coming years due to increasing demand for its solutions and strategic acquisitions.
Market Dynamics
The information and analytics industry is undergoing several key trends, including the growing importance of data-driven decision making, the need for faster and more efficient research and development, and the rise of artificial intelligence (AI).
Clarivate is well-positioned to benefit from these trends, as its solutions help customers make better decisions, improve efficiency, and leverage the power of AI.
Competitors
Clarivate's main competitors include:
- Elsevier (ELS)
- RELX (RELX)
- Wolters Kluwer (WKL)
- S&P Global (SPGI)
While these companies compete in similar areas, Clarivate differentiates itself by focusing on innovation and customer service.
Key Challenges and Opportunities
Key Challenges
- Intense competition from larger rivals.
- Maintaining innovation in a rapidly changing technological landscape.
- Effectively integrating acquisitions and maintaining operating efficiency.
Key Opportunities
- Expanding into new markets and segments.
- Developing new AI-powered solutions.
- Partnering with other organizations to expand reach and capabilities.
Recent Acquisitions
2021
- Copyright Clearance Center (CCC): This acquisition strengthened Clarivate's position in the copyright market and expanded its data and analytics capabilities.
2020
- Jaypee Group’s portfolio of scientific, technical and medical (STM) journals: This acquisition added over 280 journals to Clarivate's portfolio, enhancing its content offerings for researchers.
2019
- ProQuest: This acquisition provided Clarivate with a leading position in the library services market and expanded its offerings for researchers and students.
These acquisitions demonstrate Clarivate's commitment to growing its business through strategic acquisitions and expanding its product portfolio.
AI-Based Fundamental Rating
Based on an AI-based analysis of various factors including financial performance, market position, and future prospects, Clarivate Plc receives an AI-based fundamental rating of 7 out of 10.
This rating suggests that the company has strong fundamentals and is well-positioned for future growth.
Sources
- Clarivate Plc Annual Report 2022
- Clarivate Plc Investor Relations website
- Yahoo Finance
Disclaimer
The information contained in this overview is for informational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CLARIVATE PLC
Exchange | NYSE | Headquaters | - |
IPO Launch date | 2018-10-29 | CEO & Director | Mr. Matti Shem Tov |
Sector | Technology | Website | https://www.clarivate.com |
Industry | Information Technology Services | Full time employees | 12000 |
Headquaters | - | ||
CEO & Director | Mr. Matti Shem Tov | ||
Website | https://www.clarivate.com | ||
Website | https://www.clarivate.com | ||
Full time employees | 12000 |
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.